[Sub-acute hepatotoxicity of low doses of microcystins]

Wei Shi1, Huigang Zhu, Xiaorong Yan

  • 1School of Public Health, Fudan University, Shanghai 200032, China.

Insights

This study reveals that low-dose microcystin exposure in rats causes liver damage, indicated by altered enzyme levels and cellular changes. Oxidative stress and hepatocyte apoptosis are key mechanisms driving microcystin-induced hepatotoxicity.

Area of Science:

  • Environmental toxicology
  • Hepatology
  • Biochemistry

Background:

  • Microcystins (MCs) are potent cyanotoxins with known hepatotoxic effects.
  • Understanding the sub-acute effects and mechanisms of low-dose MC exposure is crucial for risk assessment.

Purpose of the Study:

  • To investigate the sub-acute hepatotoxicity of low-dose microcystins in vivo.
  • To elucidate the underlying mechanisms of microcystin-induced liver injury.

Main Methods:

  • Eighty Sprague-Dawley rats were administered varying doses of microcystins (0, 4, 8, 12 µg/kg/day) for 35 days.
  • Blood and liver samples were analyzed for enzymatic levels (GGT, LDH, AST, ALT) and glutathione (GSH) concentrations.
  • Apoptosis and cell proliferation were assessed using TUNEL and PCNA immunohistochemistry.

Main Results:

  • Microcystin exposure led to decreased serum gamma-glutamyltransferase (GGT) and whole blood glutathione (GSH) levels.
  • Increased serum lactate dehydrogenase (LDH) and aminotransferase (AST) activities were observed.
  • Hepatocytes exhibited morphological alterations, increased proliferation, and apoptosis.

Conclusions:

  • Low-dose microcystin exposure induces sub-acute hepatotoxicity in rats.
  • Oxidative injury and apoptosis of hepatocytes are suggested as primary mechanisms of microcystin hepatotoxicity.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...